APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.

APCL, a central nervous system-specific sequence homologue of the adenomatous polyposis coli tumor suppressor, can regulate the cytoplasmic level of beta-catenin as the adenomatous polyposis coli tumor suppressor does, but its overall biological function remains unclear. Using a yeast two-hybrid system, we attempted to isolate proteins that might associate with the unique COOH-terminus of APCL. Among 166 cDNA clones isolated from a human fetal-brain cDNA library as candidates for interaction with APCL, 32 encoded parts of p53-binding protein 2 (53BP2), a molecule that interacts with p53 and Bcl2. An in vitro binding assay indicated that the Src-homology-3 domain and the ankyrin-repeat domain of 53BP2 were both required for binding to the COOH-terminus of APCL. Confocal microscopy showed that APCL and 53BP2 proteins were localized together in the perinuclei of normal mammalian cells, but this was not the case in cells that expressed truncated APCL and 53BP2 proteins. These findings suggested that binding of the COOH-terminus of APCL to 53BP2 regulates the cytoplasmic location of 53BP2. Because 53BP2 also interacts with p53 and Bcl2 and regulates p53 function, our results suggest that APCL might be involved in the p53/Bcl2-linked pathway of cell-cycle progression and cell death.

[1]  中川 英刀.  Identification of a brain-specific APC homologue, APCL, and its interaction with β-catenin , 2000 .

[2]  Y. Nakamura,et al.  Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin. , 1998, Cancer research.

[3]  Bin Li,et al.  Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2* , 1998, The Journal of Biological Chemistry.

[4]  J. Yasuda,et al.  A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.

[5]  N. Pavletich,et al.  Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2 , 1996, Science.

[6]  M. Cleary,et al.  The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M , 1996, Molecular and cellular biology.

[7]  T. Akiyama,et al.  Binding of APC to the Human Homolog of the Drosophila Discs Large Tumor Suppressor Protein , 1996, Science.

[8]  John D. Scott,et al.  Molecular Glue: Kinase Anchoring and Scaffold Proteins , 1996, Cell.

[9]  R. Brent,et al.  APC binds to the novel protein EB1. , 1995, Cancer research.

[10]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Pollard,et al.  Wild-type but not mutant APC associates with the microtubule cytoskeleton. , 1994, Cancer research.

[12]  S. Fields,et al.  Two cellular proteins that bind to wild-type but not mutant p53. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Sven Berg,et al.  A repeating amino acid motif shared by proteins with diverse cellular roles , 1994, Cell.

[14]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[15]  G. Joslyn,et al.  Dimer formation by an N-terminal coiled coil in the APC protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[17]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.